Aker Philadelphia Shipyard Begins Aframax Tankers Construction Activity for SeaRiver

Aker Philadelphia Shipyard (APSI), a subsidiary of Aker Philadelphia Shipyard ASA, has started manufacturing one of the two Aframax tankers to be built for SeaRiver Maritime, an US marine affiliate of Exxon Mobil.

The construction of 820 ft long ships, which can carry 115000 t of crude oil, will be completed by 2014.

The basic work for building the ship is in progress after signing the contract in September 2011. The work started by slicing the steel plates at the fabrication shop of the shipyard after a small ceremony. The steel plates will be placed as a part of the tanker’s double hull which provides protection for cargo tanks.

The President and CEO of APSI, Kristian Rokke stated that the work is vital for production in America. The new plasma cutting equipment from Wisconsin was used to slice the steel plates procured from Pennsylvania. Several hours will be spent to weld and fabricate these plates to produce the ship to carry the oil of Alaska.

Jack Buono, the President of SeaRiver said that the Liberty Class project is a representation of the company’s devotion to safe transport.  The design incorporating vital technologies are built according to demanding global marine conditions.

Aker Philadelphia Shipyard is a commercial shipyard leader that constructs vessels for Jones Act sector. It has an excellent facility to build ships. It provides oceangoing merchant vessels with a good track record for delivery.

Source: https://www.phillyshipyard.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2022, July 22). Aker Philadelphia Shipyard Begins Aframax Tankers Construction Activity for SeaRiver. AZoBuild. Retrieved on November 24, 2024 from https://www.azobuild.com/news.aspx?newsID=15021.

  • MLA

    Scanlon, Joel. "Aker Philadelphia Shipyard Begins Aframax Tankers Construction Activity for SeaRiver". AZoBuild. 24 November 2024. <https://www.azobuild.com/news.aspx?newsID=15021>.

  • Chicago

    Scanlon, Joel. "Aker Philadelphia Shipyard Begins Aframax Tankers Construction Activity for SeaRiver". AZoBuild. https://www.azobuild.com/news.aspx?newsID=15021. (accessed November 24, 2024).

  • Harvard

    Scanlon, Joel. 2022. Aker Philadelphia Shipyard Begins Aframax Tankers Construction Activity for SeaRiver. AZoBuild, viewed 24 November 2024, https://www.azobuild.com/news.aspx?newsID=15021.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.